Showing posts with label distinct. Show all posts
Showing posts with label distinct. Show all posts
Sunday, January 31, 2010
Editorial: The heterogeneity of epithelial ovarian cancer. Getting it right David M. Gershenson
Editorial
The heterogeneity of epithelial ovarian cancer
Getting it right
David M. Gershenson, MD *
Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas
email: David M. Gershenson (DGERSHEN@mdanderson.org)
Abstract
Epithelial ovarian cancer is heterogeneous and comprises 4 major rare subtypes - mucinous, clear cell, low-grade serous, and endometrioid - all distinct from the more common high-grade serous carcinoma. Women with uncommon histotypes should be triaged to separate clinical trials.
Subscribe to:
Posts
(
Atom
)
